NewLimit, Inc. · CIK 1977037
NewLimit, Inc.
Filings
2
Original notices
1
Amendments
1
Activity
Jan 7, 2025
through May 15, 2025
through May 15, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Jan 7, 2025 · D/A | May 15, 2025 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $72,245,500 | $129,999,762 | $57,754,262 |
| Reported amount sold | $72,245,500 | $129,799,764 | $57,554,264 |
| Reported investor count | — | — | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001977037-25-000001 · Later SEC source: 0001977037-25-000002
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $129,999,762
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $129,799,764
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Likely investment adviser (not guaranteed)
Best-effort name match against Form ADV. Click through for AUM, employees, and disciplinary disclosures.
-
NEWLIN CAPITAL PARTNERS, LLC
medium CRD 801-73606
Form D filings (2)
-
0001977037-25-000002D · May 15, 2025 · BiotechnologyOffering: $129,999,762Sold: $129,799,764
Compared with 0001977037-25-000001:
- Reported offering amount: $72,245,500 → $129,999,762
- Reported amount sold: $72,245,500 → $129,799,764
-
0001977037-25-000001D/A · Jan 7, 2025 · BiotechnologyOffering: $72,245,500Sold: $72,245,500